Patients with moderately differentiated carcinoma of the juxta-abdomen need to receive early treatment. Middle-differentiated carcinoma of the jugular abdomen is a kind of malignant tumor with medium degree of malignancy, and if it can be detected, diagnosed and treated at an early stage, most of the patients can effectively control the disease and prolong the survival period. Most of the patients can effectively control the disease and prolong the survival period if early detection, early diagnosis and early treatment can be achieved. Middle-differentiated carcinoma of jugular abdominal region usually requires surgical treatment in the early stage to remove the lesion, and most of the patients can effectively prolong the survival period if they are treated with radiotherapy and chemotherapy as well as targeted drugs (e.g. bevacizumab, capecitabine, oxaliplatin) after the surgery. The related treatment should be carried out strictly under the guidance of doctors. Surgery for moderately differentiated carcinoma of the jugular abdomen is a major surgery, which is very demanding for the patients’ physical conditions. If the patients can tolerate the surgery, they should undergo surgery as early as possible, and if the patients are older and in poor physical condition, they need to undergo interventional therapy. It is suggested that patients should go to the hospital in time and be treated under the guidance of physicians so as not to delay their condition.